Direct gene delivery to synovium - An evaluation of potential vectors in vitro and in vivo

被引:150
作者
Nita, I [1 ]
Ghivizzani, SC [1 ]
GaleaLauri, J [1 ]
Bandara, G [1 ]
Georgescu, HI [1 ]
Robbins, PD [1 ]
Evans, CH [1 ]
机构
[1] UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA 15261
来源
ARTHRITIS AND RHEUMATISM | 1996年 / 39卷 / 05期
关键词
D O I
10.1002/art.1780390515
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the abilities of various vectors to transfer genes to the synovial lining of joints. Methods. Vectors derived from retrovirus, adenovirus, and herpes simplex virus as well as cationic liposomes and naked plasmid DNA were evaluated. Each construct contained the lac Z marker gene; and one retroviral construct, and one plasmid also contained a gene encoding human interleukin-1 receptor antagonist. Gene expression was under the control of the human cytomegalovirus promoter in ail vectors except the retrovirus, where the endogenous 5' long terminal repeat was retained as the promoter. Cultures of rabbit synovial fibroblasts were exposed to these vectors and stained with X-gal to identify lac Z+ cells. Vectors were then injected directly into rabbits' knee joints, and gene transfer and expression were assessed by X-gal staining and polymerase chain reaction (PCR). Results. Adenovirus was a highly effective vector both in vitro and in vivo, with lac Z gene expression persisting for at least 28 days. However, an inflammatory response was noted in vivo, Cells infected in vitro and in vivo with herpes simplex virus also expressed the lac Z gene at high levels, but expression was limited by cytotoxicity. Retroviruses, in contrast, were effective only under in vitro conditions, permitting cell division. Liposomes gave variable in vitro results; when injected into joints in vivo, gene expression was low and was detectable for only a few days, even though a PCR signal persisted for at least 28 days. Unexpectedly, plasmid DNA was captured by the synoviocytes and expressed transiently following intraarticular injection. Conclusion. None of the vectors was ideal for in vivo gene delivery to synovium, although adenovirus was clearly the most effective of those tested. Retroviruses, although poor vectors for in vivo gene delivery, are well suited for ex vivo gene transfer to the synovial lining of joints.
引用
收藏
页码:820 / 828
页数:9
相关论文
共 39 条
[1]   GENE-TRANSFER TO SYNOVIOCYTES - PROSPECTS FOR GENE TREATMENT OF ARTHRITIS [J].
BANDARA, G ;
ROBBINS, PD ;
GEORGESCU, HI ;
MUELLER, GM ;
GLORIOSO, JC ;
EVANS, CH .
DNA AND CELL BIOLOGY, 1992, 11 (03) :227-231
[2]   INTRAARTICULAR EXPRESSION OF BIOLOGICALLY-ACTIVE INTERLEUKIN-1 RECEPTOR-ANTAGONIST PROTEIN BY EX-VIVO GENE-TRANSFER [J].
BANDARA, G ;
MUELLER, GM ;
GALEALAURI, J ;
TINDAL, MH ;
GEORGESCU, HI ;
SUCHANEK, MK ;
HUNG, GL ;
GLORIOSO, JC ;
ROBBINS, PD ;
EVANS, CH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) :10764-10768
[3]   LIPOSOME-MEDIATED CFTR GENE-TRANSFER TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS [J].
CAPLEN, NJ ;
ALTON, EWFW ;
MIDDLETON, PG ;
DORIN, JR ;
STEVENSON, BJ ;
GAO, X ;
DURHAM, SR ;
JEFFERY, PK ;
HODSON, ME ;
COUTELLE, C ;
HUANG, L ;
PORTEOUS, DJ ;
WILLIAMSON, R ;
GEDDES, DM .
NATURE MEDICINE, 1995, 1 (01) :39-46
[4]   ISOLATION AND CHARACTERIZATION OF DELETION MUTANTS OF HERPES-SIMPLEX VIRUS TYPE-1 IN THE GENE ENCODING IMMEDIATE-EARLY REGULATORY PROTEIN-ICP4 [J].
DELUCA, NA ;
MCCARTHY, AM ;
SCHAFFER, PA .
JOURNAL OF VIROLOGY, 1985, 56 (02) :558-570
[5]  
EVANS C, 1994, J RHEUMATOL, V21, P779
[6]   POSSIBLE ORTHOPEDIC APPLICATIONS OF GENE-THERAPY [J].
EVANS, CH ;
ROBBINS, PD .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1995, 77A (07) :1103-1114
[7]   EXPERIMENTAL ARTHRITIS INDUCED BY INTRAARTICULAR INJECTION OF ALLOGENIC CARTILAGINOUS PARTICLES INTO RABBIT KNEES [J].
EVANS, CH ;
MAZZOCCHI, RA ;
NELSON, DD ;
RUBASH, HE .
ARTHRITIS AND RHEUMATISM, 1984, 27 (02) :200-207
[8]   PROGRESS TOWARD THE TREATMENT OF ARTHRITIS BY GENE-THERAPY [J].
EVANS, CH ;
ROBBINS, PD .
ANNALS OF MEDICINE, 1995, 27 (05) :543-546
[9]  
EVANS CH, 1995, EXPERT OPIN INV DRUG, V4, P843
[10]  
EVANS CH, 1995, MOL CELL BIOL HUMAN